000			01517 a2200409 4500
005			20250513220600.0
264		0	_c20000926
008			200009s 0 0 eng d
022			_a0899-1987
040			_aNLM _beng _cNLM
100	1		_aMaier, A
245	0	0	_aDisruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. _h[electronic resource]
260			_bMolecular carcinogenesis _cAug 2000
300			_a225-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aArsenic _xpharmacology
650	0	4	_aCadmium _xpharmacology
650	0	4	_aChromium _xpharmacology
650	0	4	_aCytochrome P-450 CYP1A1 _xbiosynthesis
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGenes, Reporter
650	0	4	_aLiver Neoplasms, Experimental
650	0	4	_aLuciferases _xgenetics
650	0	4	_aMice
650	0	4	_aNAD(P)H Dehydrogenase (Quinone) _xgenetics
650	0	4	_aPolychlorinated Dibenzodioxins _xpharmacology
650	0	4	_aRecombinant Proteins _xbiosynthesis
650	0	4	_aSuperoxide Dismutase _xgenetics
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aTransfection
650	0	4	_aTumor Cells, Cultured
650	0	4	_abeta-Galactosidase _xgenetics
700	1		_aDalton, T P
700	1		_aPuga, A
773	0		_tMolecular carcinogenesis _gvol. 28 _gno. 4 _gp. 225-35
999			_c10920429 _d10920429